News
Public · Published
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year
Dan Loeb's firm raised its Danaher stake to 540,000 shares in the second quarter of 2026 from 525,000 in the first quarter, a stake valued at about $102.8 million as of June 30, after cutting it earlier this year.
Published:
Updated:
What happened
Dan Loeb's firm raised its Danaher stake to 540,000 shares in the second quarter of 2026 from 525,000 in the first quarter, a stake valued at about $102.8 million as of June 30, after cutting it earlier this year.
Confirmed
Global impact / market context
A billionaire investor adding back shares can signal renewed confidence in Danaher's outlook. Strong quarterly results, a raised profit forecast and leadership changes give investors concrete reasons to reassess the stock's earnings trajectory.
Analyst inference
Danaher beat earnings and revenue expectations and raised its fiscal 2026 adjusted earnings forecast. Management cited improving end-market conditions, though respiratory revenue is expected to be a headwind to core revenue growth in the fourth quarter.
Analyst inference
What to watch
- Danaher's fourth-quarter 2026 guidance anticipates non-GAAP core revenue growth of 4.0% to 5.0%, which means excluding certain items, with respiratory revenue an approximately 150 basis point headwind, resulting in core revenue growth of approximately 3.0%. Confirmed
- Julie Sawyer Montgomery was appointed president and CEO and a board member, while Rainer Blair retires the same date and remains a senior advisor through March 31, 2027, to support the leadership transition. Confirmed
- Investors should watch whether Danaher delivers the guided fourth-quarter core revenue growth and whether the new CEO sustains the improving end-market momentum management cited when raising the fiscal 2026 earnings forecast. Analyst inference
Evidence
- Original source link unavailable